We read with interest the paper by Heldt and colleagues
1
who report on the benefit of combining multiple biomarkers and tests including galactomannan
(GM) ELISA assay from bronchoalveolar lavage fluid (BALF) as well as the BALF Aspergillus specific Lateral Flow Device Test (LFD) for the diagnosis of invasive pulmonary aspergillosis
(IPA) in patients with hematological malignancies.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of InfectionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Diagnosis of invasive Aspergillosis in hematological malignancy patients: performance of cytokines, asp LFD, and Aspergillus PCR in same day blood and Bronchoalveolar lavage samples.J Infect. 2018; 77: 235-241
- Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation.Bone Marrow Transpl. 2010; 45: 647-655
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.Clin Microbiol Infect. 2018; 24: e1-e38
- Global guidelines and initiatives from the European confederation of medical mycology to improve patient care and research worldwide: new leadership is about working together.Mycoses. 2018; 61: 885-894
- Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.Med Mycol. 2018; 56: 416-425
- Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary Aspergillosis.Mycoses. 2018; 61: 40-43
- Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.Mycoses. 2015; 58: 461-469
- Performance of galactomannan, beta-D-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary Aspergillosis.J Clin Microbiol. 2014; 52: 2039-2045
- Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies.J Infect. 2017; 75: 370-373
- Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clin Infect Dis. 2008; 46: 1813-1821
Article info
Publication history
Published online: November 02, 2018
Accepted:
October 15,
2018
Received in revised form:
October 8,
2018
Received:
September 30,
2018
Identification
Copyright
© 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
